Navigation Links
Anti-HIV drug has potential to prevent transmission in women

A new study from infectious disease researchers at The Miriam Hospital and Brown Medical School finds that a drug already given orally to treat HIV is also safe when applied as a vaginal microbicide gel. Microbicides are designed to prevent the sexual transmission of HIV and other sexually transmitted diseases and may be formulated as vaginal gels, foams, creams, or suppositories.

"The results of this study may change the way the research community looks at developing safe and effective microbicides," says lead author Kenneth H. Mayer, MD, an infectious disease physician at The Miriam Hospital and professor of medicine and community health at Brown Medical School, both in Providence, RI. "Analyzing the compounds that already have been shown to be successful HIV treatment drugs, and evaluating them for their potential to prevent transmission of infection is an innovative approach that shows great promise."

Published in the Feb. 28 issue of the journal AIDS, currently available online, the multi-site study suggests that as a vaginal gel, tenofovir produced mild or no side effects in both HIV positive and HIV negative women. Tenofovir is the active ingredient in the antiretroviral drug Viread made by Gilead Sciences.

Currently, there is no microbicide available that has been approved for widespread use. The tenofovir study was a safety and product acceptability study and did not evaluate if the microbicide would be effective in preventing the transmission of HIV in women. Expanded safety and effectiveness testing is needed.

"The data will pave the way for further studies that will ultimately evaluate whether the gel protects women from HIV infection," says co-author Lisa A. Maslankowski, MD, medical director of the HIV Prevention Research Division at the University of Pennsylvania School of Medicine. "As the first investigational microbicide to contain an antiretroviral agent, tenofovir gel can prevent HIV from replicating, unlike other
'"/>

Source:Lifespan


Page: 1 2 3

Related biology news :

1. Novel Enzyme Shows Potential As An Anti-HIV Target
2. MetaChip provides quick, efficient toxicity screening of potential drugs
3. Simple drug has the potential to save many lives threatened by malaria
4. Scripps scientists find potential for catastrophic shifts in Pacific ecosystems
5. Engineers improve plastics potential for use in implants by linking it to biological material
6. Human embryonic stem cells have the potential to develop into eggs and sperm in the laboratory
7. Improving the potential of cancer vaccines
8. Snapin: A protein with therapy potential for autism
9. Slipping past the blood brain barrier: Research shows potential treatment for brain cancer
10. LIAI scientists make major finding on potential smallpox treatment
11. Neurotransmitters signal aggressive cancer, offer potential for early diagnosis

Post Your Comments:
(Date:12/1/2009)...S, Ohio Ohio State University cancer researchers ...kills brain-tumor cells and blocks the growth of n...hat viruses designed to kill cancer cells oncolyt...sive brain tumors if they also carry a gene for a ...protein, called vasculostatin, is normally produce...
(Date:12/1/2009)..., NEW YORK, Dec. 1 iQor, a glob...services, was included in the 2009 InfoWorld 100...ic-enabled ERP system, TeQ21. This was the first s...cognized among this prestigious list of companies,...eQ21 is completely transforming the way we do busi...
(Date:12/1/2009)...ess, like a bad cold, can spread among groups of p...University of California-San Diego and Harvard sho...study that has been following health conditions fo...t lonely people tend to share their loneliness wit...disconnected people moves to the fringes of social...
Breaking Biology News(10 mins):Tumor-attacking virus strikes with 'one-two punch' 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Loneliness can be contagious 2Loneliness can be contagious 3Amilpar Operating Revenues Grew 9 25 in the Second Quarter and 11 25 in the First Half of 2009 54276 1Amilpar Operating Revenues Grew 9 25 in the Second Quarter and 11 25 in the First Half of 2009 54276 2Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 1Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 2Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 3Postdiagnosis aspirin use reduces risk of dying from colorectal cancer 54274 1Postdiagnosis aspirin use reduces risk of dying from colorectal cancer 54274 2
...ity of North Carolina at Chapel Hill,s newest "lib...book lover, but it eventually will please thousand...ch researchers, work, it will undoubtedly contribu...t depend on every day, its developers say. , Named...oluminous genetic data on 39 plant species. The li...
... not for fun but for fuel. Burning grass for energ...r decades. But not in the United States. , Yet bur...rgy-efficient, environmentally friendly and sustai...t. , This alternative fuel easily could be produc...stoves built to burn wood pellets or corn, says Je...
...ns infectious disease specialists who have spent m... and AIDS worldwide are warning that limited inter...es currently being distributed in Africa, Asia and... afford to pay for them. , In an article appearing...une 28, infectious disease specialist Jonathan Zen...
Other Biology News:Unique library of plant genes germinates, takes root at UNC 2Grass makes environmentally friendly biofuel 2Hopkins AIDS experts issue warning about global efforts to provide drug therapies 2Hopkins AIDS experts issue warning about global efforts to provide drug therapies 3Hopkins AIDS experts issue warning about global efforts to provide drug therapies 4
(Date:11/30/2009)...OOMINGTON, Minn., Nov. 30 Acuo Tec...image management software, data migration tools an...a Hospitals and Clinics for a new Vendor Neutral A...orage across the Allina network of hospitals, clin...s based on the Acuo Technologies DICOM Services Gr...
(Date:11/30/2009)...OCKVILLE, Md., Nov. 30 N...cine company, announced today that the company wil...ference 2009 on December 2, 2009 at 12:30 pm local...ill provide an overview of the company,s business ...coming milestones. A link to the live audio only ...
(Date:11/30/2009)... AMSTERDAM, November 30 Biopharm...at the first patients have been enrolled in its,mu...TM). The study is,designed to show reduction in tr...llowing an allogeneic stem cell transplantation wi...ancer patients eligible for an allogeneic,stem cel...
(Date:11/30/2009)... CHANGCHUN, China and LOS ANGELES, Nov. 30 /PR...uticals, Inc. (OTC Bulletin Board: CYXN; ,China Yo...g manufacturer, distributor and,retailer of pharma...t has,completed preparation for distribution of me... Chinese government recently formalized the nation...
Breaking Biology Technology:Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3
...affiliate of,Phlo Corporation (Pink Sheets: PHLC) ...ion of its vitality product, AQUISS(TM), in Califo... within Northern California and has,been introduce...with the,Palm Desert/Palm Springs area. In Northe...ndiser,Holiday Meeting, which was instrumental in ...
...se Review with Drs. Morton Kern, Nico ...en and WILMINGTON, Mass., Oct. 19 The use,of frac...utcomes is the,topic of several sessions at this y...mposium, TCT 2007, which will take place Oct. 20-2...st company to develop systems that,calculate FFR w...
...PRNewswire-FirstCall/ -- Simcere,Pharmaceutical Gr...lier of,branded generic pharmaceuticals in the rap...hat it intends to release its 2007 third quarter r...ket opens in the United States.,Simcere,s chief ex...,officer, Frank Zhigang Zhao, will host an earning...
Other Biology Technology:AQUISS Continues Expansion Into New Territory 2Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 3
Goat Anti-HIV-1 HIV1 p24 Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-Human CD11b / Mac-1alpha Monoclonal Antibody, Unconjugated, Clone LM2 / 1 from Cell Sciences
RABBIT (BABY) COMPLEMENT LYOPHILISED from AbD Serotec
Rabbit Anti-Human ZO-1 Antibody, Unconjugated from Lab Vision
Biology Products: